MUNICH —Diaverum has, through the acquisition of a clinic in Germany, passed the 20,000 patients milestone.
The acquisition in means that the company now treats dialysis patients at 15 locations in Germany. In addition, Diaverum has also just opened up new clinics in Chile and in Poland.
President and CEO of Diaverum, Dag Andersson, said he is very proud of the substantial growth that his company has accomplished over the last few years. "This milestone is another step on our journey to become the first choice in renal care. It shows that there is confidence in us as caregivers and in the quality of the care that we deliver. Our ability to grow is also of benefit to our patients, because with each treatment we are broadening our experience—today we deliver more than three million treatments annually. This means that we are becoming more and more efficient and increasingly able to offer our patients a treatment that improves their quality of life, wherever we are active."
During 2011, Diaverum entered three new markets: Chile, Saudi Arabia and Romania. In Chile, Diaverum initially acquired two renal clinics in Concepcion and later two clinics located in the growth region of Araucania in 2011. Chile is Diaverum's third country in Latin America after Argentina and Uruguay, where the company currently operates a total of 40 clinics.
In Saudi Arabia, a joint venture with Nazer Group, a Saudi Arabian holding company with major investments in the medical sector, led to the recent inauguration of a new, state-of-the-art dialysis clinic in Dammam for 200 patients. On the third new market, Romania, Diaverum acquired Clinica Dialmed which operates nine dialysis clinics with 850 patients.
Diaverum formed after Gambro Healthcare was sold in 2007 to the private-equity firm Bridgepoint. The company changed its name to Diaverum in 2008.